Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05148377Phase 3Completed
A Phase 3 trial of Heptar in chronic kidney disease (CKD), sponsored by Eurofarma. Started Aug 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05148377.